Immuneering Corp - Ordinary Shares Class A

NASDAQ:IMRX   11:08:33 AM EDT
21.72
+1.14 (+5.54%)
Earnings Announcements

Immuneering Reports Third Quarter 2021 Financial Results

Published: 11/09/2021 11:52 GMT
Immuneering Corp - Ordinary Shares Class A (IMRX) - Immuneering Reports Third Quarter 2021 Financial Results and Recent Business Highlights.
Q3 Loss per Share $0.47.
Expects to File Ind for Imm-1-104 in Q1 2022.
Revenue is expected to be $0.55 Million
Adjusted EPS is expected to be -$0.42

Next Quarter Revenue Guidance is expected to be $0.41 Million
Next Quarter EPS Guidance is expected to be -$0.43

More details on our Analysts Page.